9th Annual Biomarkers Congress

Genomics: Merck

Total Score People Score Events Score
28 23 21
Date Event Presentation Speakers
October 31, 2013 (T1) Keystone Symposia: Advancing Vaccines in the Genomics Era Systems Biological Approaches to Vaccination Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Danilo Casimiro,
Genomic and Structural Approaches to Antigen and Adjuvant Discovery, Design and Validation Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Danilo Casimiro,
October 7, 2013 Drug Discovery Week Europe (DDWE) Using System Biology Biomarkers to Combat Mechanisms of Disease Alain van Gool
September 12, 2013 The 2nd International Conference on Genomics in the Americas Integration of NGS Into Early Clinical Development in Oncology James Watters
February 3, 2013 Neurogenesis (J7) Mechanisms of Early Disease Intervention and Biomarkers Michael L. Hutton
February 3, 2013 New Frontiers in Neurodegenerative Disease Research (J8) Mechanisms of Early Disease Intervention and Biomarkers Michael L. Hutton
Tau-based Therapeutics for Alzheimer’s Disease and Related Tauopathies Michael L. Hutton
December 4, 2012 CGS – The Cancer Genome Summit How is Sequencing Technology Evolving and What Does This Mean for the Future of Drug Development? J Watters
June 20, 2011 Changing Landscape of the Cancer Genome (F3) Bridging the Gap between Cancer Genomics and Drug Discovery Giulio F Draetta
August 18, 2010 Challenges in Pre-Clinical & Clinical Development - Top 5 Challenges in Vaccines & Immunotherapeutics Development of Biomarkers of Vaccine Efficacy Against Chronic Viral Infections Danilo Casimiro,
IDENTIFYING BIOMARKERS FOR IMMUNE RESPONSE Danilo Casimiro,
Strategies for the Non-Clinical Safety Assessment of Vaccines Jayanthi Wolf
July 11, 2010 Translational Cancer Medicine 2010 (USA) The biomarker roadmap: How to integrate biomarker and compound discovery for early clinical decision making Pearl S. Huang
Why current ways of working together as patients, clinicians, and scientists could ultimately fail Stephen H Friend
May 19, 2010 Towards Personalized Cancer Medicine Integrative Genomic Models of Disease, Use of Contributor Networks Stephen H Friend
SESSION IV: Biomarkers for Prognosis/Response: Impact on Clinical Trials Stephen H Friend
Molecular Profiling of Pre-Clinical and Clinical Models: Informing the Development of Rational Combinations James Watters
PANEL DISCUSSION Stephen H Friend
May 4, 2010 Biomarker World Congress 2010 Identification of a Transcriptional Biomarker of Target Engagement and Use in Oncology Early Clinical Development Samuel C. Blackman
Practice and Pitfalls of Open Source Precompetitive Collaboration on Biomarkers John A. Wagner
From Biomarker Strategies to Biomarker Activities and Back Alain van Gool
October 6, 2009 Phage Display to Develop Therapeutic Antibodies Strategies for a Competitive Biologics Portfolio Georg Feger
September 23, 2009 TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis IT Frameworks for Supporting Analysis of Complex Data Sets in Translational Medicine Research Gary K. Mallow
June 9, 2009 Genomic Sample Prep Development of a Microarray Platform for FFPET Profiling: Application to the Classification of Human Tumors Mingjie Zhou
October 21, 2008 RNAi for Screening 1536-Well RNAi HTS Assays to Identify New Regulators of the Wnt Pathway Marc Ferrer
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic Applications of Molecular Profiling to RNA Therapeutics Aimee L Jackson
March 9, 2008 NEW ANTIBACTERIAL DISCOVERY & DEVELOPMENT New strategies to develop novel targets: Platensimycin, a selective FabF inhibitor Sheo B Singh
February 3, 2008 Biomarker Discovery, Validation and Applications Translational Medicine and the Critical Path 2 Frank D Sistare
October 15, 2007 2nd Annual Innovations in Clinical Trials: Implementations of Biomarkers (Oct15-16) ADDRESSING THE VALIDATION BOTTLENECK: Chairperson’s Remarks (11:10-11:15) Peter DePhillips
September 30, 2007 Bridging Pharma and IT - Leveraging Information Technology to Improve Productivity (Sep30-Oct2) Keynote Session 2: Creating the IT Infrastructure to Enable Adaptive Clinical Development (16:00-16:45) Jerald S. Schindler
BRIDGING DISCOVERY/DEVELOPMENT AND IT (09:30-15:30) Lori Harmon, Vic Uebele
BRIDGING DISCOVERY/DEVELOPMENT AND IT: Making the Most of Limited Resources - Creation of a Merck-wide Biologics Database (11:00-11:45) Lori Harmon, Vic Uebele
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Eight Annual Metabolic Biomarkers; METABOLITE BIOMARKERS OF TOXICITY (13:30-15:00) Qiuwei Xu
Eight Annual Metabolic Biomarkers; METABOLITE BIOMARKERS OF TOXICITY: NMR Metabolomics: Metabolites, Mechanisms, and Pathways (13:30-14:00) Qiuwei Xu
Third Annual Toxicity Biomarkers; METABOLITE BIOMARKERS OF TOXICITY: NMR Metabolomics: Metabolites, Mechanisms, and Pathways (13:30-14:00) Qiuwei Xu
Third Annual Toxicity Biomarkers; METABOLITE BIOMARKERS OF TOXICITY (13:30-15:00) Qiuwei Xu
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.